🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
CRB
$CRBU
🔒 US EquitiesCaribou Biosciences Inc
AVG HISTORICAL GAP
+0.51%
MAX GAP RECORD
+4.40%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CRBU
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CRBU
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 13, 2026 Earnings Release 2026-08-13 (AFTER CLOSE) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+1.06%
|
| Mar 05, 2026 Earnings Release 2026-03-05 (AFTER CLOSE) |
-2.92%
|
| Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE) |
+1.77%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
-3.91%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+3.29%
|
| Mar 10, 2025 Earnings Release 2025-03-10 (AFTER CLOSE) |
+1.36%
|
| Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE) |
-3.64%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.5%
Bullish Gaps (8)
Bearish Gaps (4)
Neutral / Flat (2)
📖 Intelligence Summary
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗